A Multiple Ascending Dose Study of DT-216P2 in Patients With Friedreich's Ataxia

Clinical trial NCT06874010 · RECRUITING

Trial details

NCT number: NCT06874010
Sponsor: Design Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Friedreich Ataxia

Start date: 2025-06-01
Primary completion: 2026-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.